• Activity INFORMATION

  Overview

  Chronic Obstructive Pulmonary Disease (COPD) was the fourth leading cause of death in the United States in 2018 and a significant cause of illness and disability. It affects more than 15 million Americans, though prevalence varies considerably by state, from 3.7% of adults in Hawaii to 13.6% of adults in West Virginia. Over the next 20 years, COPD is projected to incur direct medical costs of over $800 billion in the U.S. alone. The most widely utilized guidelines related to the diagnosis and treatment of COPD have been developed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the American Thoracic Society (ATS), and a collaboration between the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society (ERS). Though the majority of patients with COPD in the U.S. are cared for by primary care clinicians, the lack of COPD-related knowledge remains a significant barrier to the care of this patient population. Accordingly, familiarity with the standards of care reviewed in this article will help primary care clinicians optimize the care of patients with stable COPD.
  

  Handouts

  • Homestudy PDF :   22148H01.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recall symptoms and criteria for a diagnosis of COPD.

  Identify drug classes and combinations used to treat stable COPD including the therapeutic benefits, adverse effects, monitoring, and key counseling points.

  Identify first-line therapy based on the GOLD ABCD class and follow-up pharmacologic therapy for a patient with stable COPD.

  Nurse

  Identify drug classes and combinations used to treat stable COPD including the therapeutic benefits, adverse effects, monitoring, and key counseling points.

  Recall symptoms and criteria for a diagnosis of COPD.

  Identify first-line therapy based on the GOLD ABCD class and follow-up pharmacologic therapy for a patient with stable COPD.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-915237

  Universal Activity Number

  Pharmacist 0798-0000-22-148-H01-P
  Nurse 0798-0000-22-148-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Jessica  Wallace, PharmD, BCPS Associate Professor of Pharmacy Practice, Lipscomb University

  Jonathan  Hughes, PharmD, BCPS, BCACP Pharmacy Supervisor, Ascension Medical Group

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).